May 10, 2022 | Medicaid, Providers
The Centers for Medicare and Medicaid Services (CMS) created a new procedure code, Q0221, reflecting a revised U.S. Food and Drug Administration (FDA) emergency use dosage for AstraZeneca Evusheld (tixagevimab co- packaged with cilgabimab) monoconal antibody therapy...
May 4, 2022 | EVV News, Medicaid, Providers
Federal law requires states to implement Electronic Visit Verification for Medicaid home health care services by Jan. 1, 2023. HHSC will request a good faith effort exemption from the Centers for Medicare and Medicaid Services to extend this deadline by one year. CMS...
Apr 7, 2022 | Medicaid, Medicaid Providers, Providers
In response to the COVID-19 public health emergency, HHSC waived copayments for office visits beginning in March 2020. To comply with the Mental Health Parity and Addiction Equality Act (Pub. L. 110-343), HHSC is prohibiting co-payments for CHIP Mental Health and...
Apr 4, 2022 | Medicaid, Providers
HHSC is providing guidance to MCOs regarding Financial Management Services Agency (FMSA) requirements for providing CDS employer orientations under the Consumer Directed Services (CDS) option. On March 20, 2020, due to the public health emergency (PHE) caused by the...
Mar 17, 2022 | EVV News, Medicaid, Medicaid Providers, Providers
HHSC is postponing the Electronic Visit Verification Required Free Text Reviews for the Consumer Directed Services option starting with dates of service Jan. 1, 2022, until further notice. HHSC will publish a notice 90 days before the effective date when EVV Required...
Mar 7, 2022 | Medicaid, Medicaid Providers, Providers
Effective May 31, 2022, HHSC will stop using the Texas Medicaid Standing Order forMosquito Repellent. HHSC has extended the effective date of the current Standing Order to May 31, 2022,to ensure Medicaid-enrolled providers have adequate notice regarding...
